Research Projects
Characterization of the combined pharmacological inhibition of KRAS and JAK2 in immunocompetent models of pancreatic cancer
Dr.
Julio José Jiménez Alonso
Research Division
Cancer Division
Research program
Solid Tumors
Research group
Oncogenes and Effector Targets
Project information
Research project called Characterization of the combined pharmacological inhibition of KRAS and JAK2 in immunocompetent models of pancreatic cancer and belonging to the Oncogenes and Effector Targets group of the Cima University of Navarra.
Research team: Julio José Jiménez Alonso and Silvestre Vicent Cambra.
- Convocation: FIMA 2024 Postdoctoral AECC
- Reference: POSTD246238JIME
- Start date: November 15, 2024
- End date: November 14, 2027
- Funder: Asociación Española contra el Cáncer
- Grant: 160.000
- Nature of project: National
- Award year 2024
Need more information?
If you are interested in learning more about our research, please contact us.